Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer
חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2
מצבים רפואיים
TNBC · TNBC - Triple-Negative Breast Cancer · Early Stage Triple-Negative Breast Carcinoma
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Cedars-Sinai Medical Center, Los Angeles, California, United States
Contact: Study coordinator (Clinical Trial Recruitment Navigator) · GroupCancerTrialInformation@cshs.org · 310-423-2133Contact: Principal Investigator (Yuan Yuan, MD, PhD)Cedars-Sinai Medical Center Beverly Hills, Los Angeles, California, United States
Contact: Study coordinator (Clinical Trial Recruitment Navigator) · GroupCancerTrialInformation@cshs.org · 310-423-2133Jin Sun Bitar, MD (Sub-investigator)Stephen Shiao, MD, PhD (Sub-investigator)Dorothy Park, MD (Sub-investigator)Maryliza El-Masry, MD (Sub-investigator)Philomena McAndrew, MD (Sub-investigator)Huntington Cancer Center, an Affiliate of CS Cancer, Pasadena, California, United States
Contact: Study coordinator (Clinical Trial Recruitment Navigator) · GroupCancerTrialInformation@cshs.org · 310-423-2133Niki Tank, MD (Sub-investigator)Tina Wang, MD (Sub-investigator)Tiffany Shaw, MD (Sub-investigator)Hunt Cancer Institute, an Affiliate of CS Cancer, Torrance, California, United States
Swati Sikaria, MD (Sub-investigator)David Chan, MD (Sub-investigator)Vanessa Dickey, MD (Sub-investigator)Hugo Hool, MD (Sub-investigator)Andrew Horodner, MD (Sub-investigator)Syed Jilani, MD (Sub-investigator)Thomas Lowe, MD (Sub-investigator)Justin Tiulim, MD (Sub-investigator)
מובילי המחקר
Yuan Yuan, MD
Principal Investigator
Cedars-Sinai Medical Center